This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Ideaya Biosciences, Inc., Glaxosmithkline Intellectual Property (No.4) Limited. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 15 
1 out of 1 Years Active: 2025-2026
Title: Ethan DeNardo Mcspadden: Innovator in Thiadiazolyl Derivatives
Introduction
Ethan DeNardo Mcspadden is a notable inventor based in South San Francisco, CA. He has made significant contributions to the field of chemistry, particularly with his work on thiadiazolyl derivatives. His innovative approach has led to the development of a patent that showcases his expertise and creativity.
Latest Patents
Ethan holds a patent for thiadiazolyl derivatives, specifically disclosed in his work as Formula (I). This patent represents a key advancement in the field and highlights his ability to contribute valuable knowledge and solutions.
Career Highlights
Ethan is currently employed at Ideaya Biosciences, Inc., where he continues to push the boundaries of scientific research and innovation. His role at the company allows him to collaborate with other talented professionals in the industry.
Collaborations
Ethan has worked alongside notable colleagues such as Paul A. Barsanti and Hilary Plake Beck. These collaborations have further enriched his experience and contributed to the success of his projects.
Conclusion
Ethan DeNardo Mcspadden is a dedicated inventor whose work on thiadiazolyl derivatives exemplifies his commitment to innovation in the field of chemistry. His contributions are paving the way for future advancements and demonstrate the importance of collaboration in scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile